329 related articles for article (PubMed ID: 18713246)
1. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia.
den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
Haemophilia; 2009 Jan; 15(1):83-90. PubMed ID: 18713246
[TBL] [Abstract][Full Text] [Related]
2. Outcome in moderate haemophilia.
den Uijl I; Biesma D; Grobbee D; Fischer K
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s330-6. PubMed ID: 23245711
[TBL] [Abstract][Full Text] [Related]
3. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
Fischer K; Collins P; Björkman S; Blanchette V; Oh M; Fritsch S; Schroth P; Spotts G; Ewenstein B
Haemophilia; 2011 May; 17(3):433-8. PubMed ID: 21299740
[TBL] [Abstract][Full Text] [Related]
4. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
Taki M; Shirahata A
Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
[TBL] [Abstract][Full Text] [Related]
5. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
Ahnström J; Berntorp E; Lindvall K; Björkman S
Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
[TBL] [Abstract][Full Text] [Related]
6. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
[TBL] [Abstract][Full Text] [Related]
7. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
Khawaji M; Astermark J; Berntorp E
Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis in people with haemophilia.
Coppola A; Franchini M; Tagliaferri A
Thromb Haemost; 2009 Apr; 101(4):674-81. PubMed ID: 19350110
[TBL] [Abstract][Full Text] [Related]
9. Haemophilia care in Europe: the ESCHQoL study.
Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
[TBL] [Abstract][Full Text] [Related]
10. Is on-demand treatment effective in patients with severe haemophilia?
Aznar JA; Marco A; Jiménez-Yuste V; Fernández-Fontecha E; Pérez R; Soto I; Parra R; Moreno M; Mingot ME; Moret A;
Haemophilia; 2012 Sep; 18(5):738-42. PubMed ID: 22537601
[TBL] [Abstract][Full Text] [Related]
11. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
[TBL] [Abstract][Full Text] [Related]
12. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
[TBL] [Abstract][Full Text] [Related]
13. Association between joint bleeds and Pettersson scores in severe haemophilia.
Fischer K; van Hout BA; van der Bom JG; Grobbee DE; van den Berg HM
Acta Radiol; 2002 Sep; 43(5):528-32. PubMed ID: 12423465
[TBL] [Abstract][Full Text] [Related]
14. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.
den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
Haemophilia; 2011 Jan; 17(1):41-4. PubMed ID: 20825504
[TBL] [Abstract][Full Text] [Related]
15. A comparison between prophylaxis and on demand treatment for severe haemophilia.
Khoriaty R; Taher A; Inati A; Lee C
Clin Lab Haematol; 2005 Oct; 27(5):320-3. PubMed ID: 16178913
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
Fischer K; Valentino L; Ljung R; Blanchette V
Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
[TBL] [Abstract][Full Text] [Related]
17. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China.
Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J
Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111
[TBL] [Abstract][Full Text] [Related]
18. Domiciliary application of CryoCuff in severe haemophilia: qualitative questionnaire and clinical audit.
d'Young AI
Haemophilia; 2008 Jul; 14(4):823-7. PubMed ID: 18462382
[TBL] [Abstract][Full Text] [Related]
19. Clinical severity of haemophilia A: does the classification of the 1950s still stand?
Den Uijl IE; Mauser Bunschoten EP; Roosendaal G; Schutgens RE; Biesma DH; Grobbee DE; Fischer K
Haemophilia; 2011 Nov; 17(6):849-53. PubMed ID: 21545376
[TBL] [Abstract][Full Text] [Related]
20. Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study.
Khair K; Mazzucconi MG; Parra R; Santagostino E; Tsakiris DA; Hermans C; Oldenburg J; Spotts G; Steinitz-Trost K; Gringeri A
Haemophilia; 2018 Jan; 24(1):85-96. PubMed ID: 29044825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
